Ramsay Générale de Santé SA (GDS.PA) • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold GDS.PA in your mock portfolio yet.
The company is currently loss‑making, as indicated by negative EPS and a negative P/E ratio, which points to weak underlying profitability. While healthcare demand is structurally resilient, the current earnings profile suggests operational or cost pressures that are not yet fully resolved.
The stock’s recent price action and technical setup are constructive. Trading at €11.20, it is meaningfully above its 200‑day moving average of €9.93 and has gained 8.7% over the last month, suggesting positive momentum and improving investor sentiment.
Alternative data present a mixed but slightly constructive picture. Hiring has ticked down modestly, which may indicate cost discipline or slower expansion, while social media presence—especially on consumer‑facing platforms—is growing, hinting at stronger brand engagement and marketing reach.
Overall sentiment on Ramsay Générale de Santé SA is neutral: technicals and engagement data lean positive, but current financial performance is weak with negative earnings. The market appears to be pricing in some degree of improvement, yet the lack of profitability keeps the risk profile elevated.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started